Progesterone receptor antagonists

Details for Australian Patent Application No. 2007321848 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Petrov, Orlin; Schultze-Mosgau, Marcus; Fuhrmann, Ulrike; Pruehs, Stefan; Schmidt, Anja; Moeller, Carsten; Rottmann, Antje; Cleve, Arwed; Garke, Gunnar; Hasselmann, Rainer; Brudny-Kloeppel, Margarete

Agent Davies Collison Cave

Pub. Number AU-A-2007321848

PCT Pub. Number WO2008/058767

Priority 10 2006 054 535.4 15.11.06 DE

Filing date 14 November 2007

Wipo publication date 22 May 2008

International Classifications

C07J 1/00 (2006.01) Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing carbon, hydrogen, halogen, or oxygen

A61K 31/567 (2006.01) - substituted in position 17 alpha, e.g. mestranol, norethandrolone

A61P 5/36 (2006.01) Drugs for disorders of the endocrine system

C07J 21/00 (2006.01) Normal steroids containing carbon, hydrogen, halogen, or oxygen, having an oxygen-containing hetero ring spiro-condensed with the cyclopenta[a]hydrophenanthrene skeleton

C07J 51/00 (2006.01) Normal steroids with unmodified cyclopenta[a]hydrophenanthrene skeleton not provided for in groups

Event Publications

25 June 2009 PCT application entered the National Phase

  PCT publication WO2008/058767 Priority application(s): WO2008/058767

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007321877-Pharmaceutical manufacturing methods

2007321841-Method of differentially diagnosing dementias